| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
September 13, 2005 |
|
|
| |
|
|
| |
|
|
|
Strategic Research Institute, Washington Marriott, 1221 22nd Street, NW, Washington DC
Nov. 17-18, 2005
On January 1, 2006 new regulations approved under the Medicare Modernization Act (MMA) are scheduled to take effect, providing prescription drug benefits to over 42 million eligible seniors. The pharmaceutical industry has had to prepare for Medicare Part D with many variables left unknown such as which plan sponsors will manage the benefit, which drugs will be on Part D formularies, and how many beneficiaries will actually enroll. There are, however, several key milestones from now until the end of the year during which key pieces of information will be disclosed by CMS.
|
|
|
|
|
|
|
|
Organized by:
|
|
Glenn Pascual |
|
|
Invited Speakers:
|
|
.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
September 23rd
|
|
|
|
|
|
|
|
Registration:
|
|
Early registration discounted until September 23, 2005.
|
|
|
E-mail:
|
|
info@srinstitute.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|